FDA Clearance Tracker · P210007-S008
Vivistim® Paired VNS System
Last checked: Nov 20, 2026Latest source record: Feb 26, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Feb 26, 2026
Approved
Time to decision
92 days
Received Nov 26, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P210007-S008
- Device name
- Vivistim® Paired VNS System
- Applicant
- Mobia Medical, Inc.
- Applicant location
- Austin, TX
- Received
- Nov 26, 2025
- Decided
- Feb 26, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P210007
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for expansion of MN Ops Center capabilities, including component receiving inspection & acceptance, in-house manufacturing and software installation of Stroke Application & Programming software (SAPS), routine software/firmware upgrades, and device relabeling.
Source documents
Other decisions for Mobia Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Vivistim® SystemBreakthroughPMA
P210007 · Decided Aug 27, 2021 · 178 days after receipt
Device type: Stimulator, autonomic nerve, implanted for stroke rehabilitation (QPY) · Physical Medicine & Rehabilitation
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.